PMEI28 Antibody

Shipped with Ice Packs
In Stock

Description

Absence of Direct References

The term "PMEI28 Antibody" does not appear in any of the provided sources ( ) or in standard antibody databases such as The Antibody Society’s therapeutic product list or the Histone Antibody Specificity Database .

Potential Explanations for the Missing Information

  • Nomenclature Discrepancy: The name may involve typographical errors, non-standard formatting (e.g., "PMEI-28"), or alternative identifiers (e.g., catalog numbers, gene targets).

  • Research Stage: The antibody might be in early preclinical development without published data.

  • Proprietary Status: It could be a proprietary compound under confidential development by a pharmaceutical or biotech company.

Recommendations for Further Investigation

To resolve this ambiguity, consider the following steps:

ActionPurposeResources
Verify nomenclatureConfirm spelling and formattingPubMed, Google Scholar, AntibodySociety.org
Explore gene/protein targetsIdentify if "PMEI28" refers to a target antigenUniProt, NCBI Protein Database
Contact manufacturersQuery antibody suppliers directlyAbcam , Sino Biological , Thermo Fisher Scientific

Related Antibody Classes for Context

While PMEI28 remains uncharacterized, below is a comparative overview of well-studied antibody types for reference:

Antibody TypeStructureFunctionTherapeutic Use
IgG1 Y-shaped, two heavy/light chainsOpsonization, neutralizationCancer, autoimmune diseases
IgA Dimer with secretory componentMucosal immunityInfectious disease prevention
Bispecific antibodies Dual antigen-binding sitesTarget engagementOncology, immunotherapy

Critical Considerations for Antibody Validation

If PMEI28 is a novel antibody, adhere to best practices for validation :

  1. Use CRISPR-edited knockout controls to confirm specificity.

  2. Test across multiple applications (e.g., western blot, immunofluorescence).

  3. Prioritize recombinant antibodies for reproducibility .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PMEI28 antibody; Os08g0108100 antibody; LOC_Os08g01670 antibody; P0450B04.30 antibody; Pectinesterase inhibitor 28 antibody; Pectin methylesterase inhibitor 28 antibody; OsPMEI28 antibody
Target Names
PMEI28
Uniprot No.

Target Background

Function
PMEI28 Antibody is a pectin methylesterase (PME) inhibitor that demonstrates in vitro activity against PME. It plays a crucial role in structural modulation by regulating the degree of pectin methylesterification and influencing the physiochemical properties of cell wall components.
Database Links

KEGG: osa:4344463

UniGene: Os.5834

Protein Families
PMEI family
Subcellular Location
Secreted, extracellular space, apoplast.
Tissue Specificity
Expressed in roots, leaves, culms and flag leaves.

Q&A

What is PMEI28 and what role does it play in plant biology?

PMEI28 is a pectin methylesterase inhibitor protein found in Oryza sativa (rice). Like other PMEIs, it functions by regulating the activity of pectin methylesterases (PMEs), which are enzymes that catalyze the demethylesterification of homogalacturonan domains of pectin in the plant cell wall . This regulation is crucial for:

  • Maintaining cell wall integrity during pathogen attacks

  • Controlling pectin degradation as part of the plant immune response

  • Influencing the methylesterification status of pectin, which can affect plant resistance to diseases

PMEIs like PMEI28 form specific and stable complexes with PMEs in a 1:1 stoichiometry, effectively covering the pectin-binding cleft of PME and concealing the putative catalytic sites, thereby preventing substrate approach .

How is the PMEI28 antibody typically produced and validated?

The PMEI28 antibody is produced through standard immunization protocols using either purified PMEI28 protein or synthetic peptides corresponding to specific regions of the PMEI28 sequence. Based on general antibody production methodologies and available information on similar antibodies :

  • Production Process:

    • Synthesis of immunogens (full protein or peptide fragments)

    • Immunization of host animals (typically rabbits for polyclonal antibodies)

    • Collection and purification of antibodies

    • Validation through specificity testing

  • Validation Methods:

    • Western blotting against purified PMEI28 and plant tissue extracts

    • Immunohistochemistry on plant tissues

    • ELISA to determine binding affinity and specificity

    • Cross-reactivity testing against related PMEIs

Researchers should verify the antibody's specificity through appropriate controls, including pre-immune serum and testing in PMEI28 knockout plant tissues .

What are the recommended applications for PMEI28 antibody in plant research?

Based on the applications of similar PMEI antibodies, the PMEI28 antibody can be used for :

  • Western blotting: To detect and quantify PMEI28 expression in different plant tissues, developmental stages, or in response to stress conditions.

  • Immunohistochemistry/Immunofluorescence: To localize PMEI28 protein in plant tissues and cells, providing insights into its spatial distribution.

  • ELISA: For quantitative detection of PMEI28 in plant extracts.

  • Tissue printing: To detect and localize PMEI28 in fresh plant tissue sections.

  • Immunoprecipitation: To isolate PMEI28 and its interacting partners from plant extracts.

ApplicationRecommended DilutionSample PreparationDetection Method
Western Blot1:500-1:3000Total protein extraction with buffer containing protease inhibitorsHRP-conjugated secondary antibody
Immunohistochemistry1:20-1:200Fixation with 4% paraformaldehyde, paraffin embeddingDAB or fluorescent detection
ELISA1:1000-1:5000Protein extraction in carbonatebuffer (pH 9.6)TMB substrate
Immunoprecipitation5 μg antibody per 1 mg total proteinExtraction in non-denaturing conditionsProtein A/G beads

How should I optimize antibody titration for PMEI28 detection in different plant tissues?

Optimizing antibody titration for PMEI28 detection requires systematic testing of different concentrations, as antibody performance can vary across tissue types and experimental conditions. Based on studies with similar antibodies :

  • Recommended Titration Approach:

    • Start with a fourfold dilution series (e.g., 1:500, 1:2000, 1:8000)

    • Test each dilution on your tissue of interest

    • Evaluate signal-to-noise ratio at each concentration

    • Select the dilution that gives the best specific signal with minimal background

  • Tissue-Specific Considerations:

    • Higher antibody concentrations (1:500) may be needed for tissues with low PMEI28 expression

    • Lower concentrations (1:2000-1:8000) often work well for high-expression tissues

    • Consider reducing both antibody concentration and staining volume for tissues with high background

Research shows that antibody concentrations above 2.5 μg/mL often show high background with limited response to titration, while concentrations between 0.62-2.5 μg/mL typically reach saturation plateau. Many antibodies can be further diluted without compromising detection of positive cells .

How can I ensure specificity when using PMEI28 antibody in experiments with multiple PMEI proteins?

Ensuring specificity when studying plant tissues that express multiple PMEI proteins can be challenging. Here are methodological approaches to ensure specificity :

  • Pre-absorption Controls:

    • Incubate the antibody with purified PMEI28 protein prior to the experiment

    • If the signal disappears, it confirms specificity for PMEI28

  • Knockout/Knockdown Verification:

    • Test the antibody in PMEI28 knockout or RNAi knockdown plant tissues

    • Absence or significant reduction of signal confirms specificity

  • Peptide Competition Assay:

    • Perform parallel experiments with antibody pre-incubated with the immunizing peptide

    • Signal reduction indicates specific binding

  • Cross-Reactivity Testing:

    • Express recombinant versions of related PMEIs (e.g., PMEI10, PMEI11, PMEI12)

    • Test antibody binding to determine potential cross-reactivity

  • Computational Epitope Analysis:

    • Perform in silico analysis of the antibody's epitope region across different PMEIs

    • Identify unique sequence regions specific to PMEI28

MethodAdvantagesLimitationsRequired Materials
Pre-absorptionDirect evidence of specificityRequires purified proteinRecombinant PMEI28
Knockout VerificationGold standard for specificityRequires genetic resourcesPMEI28 knockout plants
Peptide CompetitionSimple to implementWorks only for peptide antibodiesImmunizing peptide
Cross-Reactivity TestingComprehensive specificity profileLabor intensiveMultiple PMEI proteins
Computational AnalysisNo wet lab work requiredPredictive onlySequence data, modeling software

What are the optimal fixation and antigen retrieval methods for PMEI28 immunolocalization in plant tissues?

Fixation and antigen retrieval are critical steps for successful immunolocalization of PMEI28. Based on protocols for similar plant proteins :

  • Recommended Fixation Methods:

    • 4% paraformaldehyde in phosphate-buffered saline (PBS) for 12-24 hours at 4°C

    • Alternative: Farmer's fixative (3:1 ethanol:acetic acid) for 24 hours at room temperature

    • For electron microscopy: 2.5% glutaraldehyde followed by 1% osmium tetroxide

  • Optimal Antigen Retrieval Protocols:

    • Heat-mediated: Citrate buffer (pH 6.0) for 20 minutes at 95°C

    • Enzymatic: Proteinase K (20 μg/mL) treatment for 10 minutes at room temperature

    • Combined approach: Low pH treatment followed by mild enzymatic digestion

  • Tissue-Specific Considerations:

    • Leaf tissues: Additional permeabilization with 0.1% Triton X-100 may be required

    • Root tissues: Extended fixation (24-48 hours) often improves results

    • Fruit tissues: Vacuum infiltration during fixation improves penetration

After fixation and sectioning, a blocking step with 3-5% BSA or normal serum from the secondary antibody host species is recommended to reduce background staining.

How can I quantitatively assess PMEI28 interactions with different PMEs using antibody-based approaches?

Quantitative assessment of PMEI28-PME interactions requires specialized antibody-based techniques. Based on methodologies used for other PMEI-PME interactions :

  • Co-Immunoprecipitation (Co-IP) with Quantification:

    • Immunoprecipitate PMEI28 using the specific antibody

    • Analyze co-precipitated PMEs by mass spectrometry or Western blotting

    • Quantify interaction strength using calibrated standards

  • Surface Plasmon Resonance (SPR):

    • Immobilize purified PMEI28 antibody on a sensor chip

    • Capture PMEI28 from plant extracts

    • Measure binding kinetics (kon, koff) of different PMEs

    • Calculate equilibrium dissociation constants (KD)

  • Förster Resonance Energy Transfer (FRET):

    • Label PMEI28 antibody with donor fluorophore

    • Label PME antibodies with acceptor fluorophore

    • Measure FRET efficiency to determine interaction proximity

    • Calculate interaction distances

  • Enzyme-Linked Immunosorbent Assay (ELISA)-Based Binding Assays:

    • Coat plates with PMEI28 antibody

    • Capture PMEI28 from plant extracts

    • Add purified PMEs and detect binding through PME-specific antibodies

    • Generate binding curves for different PMEs

MethodQuantitative ParameterDetection LimitAdvantagesLimitations
Co-IP + MSRelative abundance~1 ng proteinIdentifies novel interactorsSemi-quantitative
SPRKD, kon, koff1-10 pMReal-time kineticsRequires specialized equipment
FRETFRET efficiency, distance1-10 nmSpatial informationComplex optimization
ELISAEC50, Bmax0.1-1 ng/mLHigh-throughputIndirect measurement

How does PMEI28 expression change during pathogen infection compared to other defense-related PMEIs?

PMEI28 expression patterns during pathogen infection can be studied alongside other defense-related PMEIs to understand their coordinated roles. Based on studies of PMEIs in pathogen response :

  • Temporal Expression Profiling:

    • Use PMEI28 antibody for Western blot analysis at different time points post-infection

    • Compare with expression patterns of other defense-related PMEIs (e.g., PMEI10, PMEI11, PMEI12)

    • Correlate with pathogen progression and disease symptoms

  • Spatial Expression Analysis:

    • Perform immunohistochemistry using PMEI28 antibody on infected tissues

    • Map expression relative to infection sites

    • Compare localization with other PMEIs to identify spatial coordination

Research on Arabidopsis PMEIs shows distinct temporal expression patterns during pathogen infection:

  • PMEI3 shows early down-regulation (24 hpi) that continues through infection

  • PMEI11 is rapidly repressed (24 hpi), then induced (48 hpi), and declines (72 hpi)

  • PMEI10 and PMEI12 show significant induction at 48 hpi that increases at 72 hpi

Additionally, different PMEIs show varied responses to defense hormones:

  • Jasmonic acid (JA) induces maximum PMEI11 expression after 24 hours

  • Ethylene (ET) causes slow increase in PMEI expression, peaking at 30 hours

  • Hydrogen peroxide (H₂O₂) affects different PMEIs distinctly

PMEIEarly Response (0-24h)Mid Response (24-48h)Late Response (48-72h)Primary Hormonal Regulation
PMEI3Down-regulationContinued decreaseLowest expressionEthylene
PMEI10Minimal changeSignificant inductionFurther increaseJasmonic acid
PMEI11Rapid repressionInductionDeclineJasmonic acid, OGs
PMEI12Minimal changeSignificant inductionFurther increaseJasmonic acid
PMEI28*Research needed using the antibody to establish precise patterns

Note: The exact pattern for PMEI28 would need to be determined through research using the PMEI28 antibody.

How can computational modeling enhance PMEI28 antibody epitope mapping and binding prediction?

Computational modeling can significantly enhance PMEI28 antibody research through epitope prediction and binding analysis :

  • Structural Modeling and Epitope Prediction:

    • Generate 3D models of PMEI28 using homology modeling based on known PMEI structures

    • Predict surface-exposed regions likely to serve as antibody epitopes

    • Calculate surface electrostatic potential to identify charged epitope regions

    • Analyze sequence conservation across species to identify unique epitope regions

  • Antibody-Antigen Docking Simulations:

    • Model the variable regions of the PMEI28 antibody

    • Perform computational docking to predict binding configurations

    • Calculate binding energies to identify high-affinity interactions

    • Simulate molecular dynamics to assess stability of antibody-antigen complexes

  • Machine Learning Approaches:

    • Train models on known antibody-antigen interactions

    • Predict PMEI28-specific binding based on sequence and structural features

    • Generate customized specificity profiles for antibody optimization

    • Design experiments to validate computational predictions

Current approaches allow researchers to:

  • Disentangle different binding modes associated with specific ligands

  • Design antibodies with customized specificity profiles

  • Predict cross-reactivity with related proteins

  • Optimize antibody sequences for improved specificity

Computational MethodFunctionRequired InputOutputApplications
Homology Modeling3D structure predictionPMEI28 sequencePredicted 3D structureEpitope mapping
Surface AnalysisIdentification of exposed regions3D modelSurface mapsAntibody design
Molecular DockingBinding predictionAntibody and antigen structuresBinding configurationsBinding optimization
Machine LearningSpecificity predictionTraining data from related antibodiesSpecificity profilesCustom antibody design

What are the common causes of high background when using PMEI28 antibody and how can they be addressed?

High background is a common challenge when working with antibodies in plant tissues. For PMEI28 antibody, the following methodological approaches can help reduce background based on research with similar antibodies :

  • Antibody Concentration Optimization:

    • High antibody concentrations (>2.5 μg/mL) often lead to increased background

    • Titrate antibody to find optimal concentration (typically 0.62-2.5 μg/mL)

    • Research shows fourfold dilutions from starting concentration allow systematic evaluation of signal-to-noise ratio

  • Blocking Improvements:

    • Extended blocking (2-4 hours) with 5% non-fat dry milk in TBS-T

    • Addition of 0.1-0.5% detergent (Triton X-100 or Tween-20) to reduce non-specific binding

    • Use of plant-specific blocking agents (e.g., 2% BSA with 10% normal serum)

  • Washing Protocol Optimization:

    • Increased washing duration (4-6 washes of 10 minutes each)

    • Higher detergent concentration in wash buffers (0.1-0.3% Tween-20)

    • Addition of salt (up to 500 mM NaCl) to wash buffers to reduce ionic interactions

  • Sample Preparation Improvements:

    • Pre-incubation of samples with pre-immune serum

    • Sample pre-clearing with Protein A/G beads

    • For plant tissues: pre-treatment with plant-specific Fc-blocking reagents

A study on antibody optimization found that antibody background in empty droplets constituted a major fraction of total sequencing reads and was skewed toward antibodies used at high concentrations targeting epitopes present in low amounts .

How can I distinguish between active and inactive PMEI28 using antibody-based detection methods?

Distinguishing between active and inactive forms of PMEI28 requires specialized approaches that go beyond simple detection. Based on techniques developed for other PMEIs :

  • Activity-Based Detection:

    • Use biotinylated PME proteins as probes

    • Only active PMEI28 will form complexes with these probes

    • Detect complexes using the PMEI28 antibody and streptavidin-based detection

  • Conformation-Specific Antibody Approach:

    • Develop and use antibodies that specifically recognize the active conformation of PMEI28

    • Compare results with the total PMEI28 detected by standard antibodies

    • Calculate the ratio of active to total PMEI28

  • Complex Formation Analysis:

    • Use high-performance size-exclusion chromatography (HPSEC)

    • Detect PMEI28-PME complexes using the antibody

    • Only active PMEI28 will form these complexes

Research on PMEIs has shown that bPMEI (biotinylated PMEI) only detected active PME molecules, while anti-PME antibodies recognized both native and denatured PMEs. This complementary approach can be adapted for PMEI28 to distinguish between active and inactive forms .

What strategies can address cross-reactivity between PMEI28 antibody and other plant proteins?

Cross-reactivity issues can significantly impact PMEI28 antibody applications. Based on antibody cross-reactivity research and specificity engineering approaches :

  • Absorption Pre-Treatment:

    • Pre-incubate antibody with purified cross-reactive proteins

    • Remove antibodies bound to non-target proteins

    • Use the remaining antibody fraction for specific detection

  • Epitope-Focused Antibody Development:

    • Identify unique epitopes in PMEI28 not present in related proteins

    • Develop new antibodies targeting these unique regions

    • Validate specificity against a panel of related PMEIs

  • Two-Antibody Validation Approach:

    • Use two different antibodies targeting distinct epitopes on PMEI28

    • Only signals that colocalize from both antibodies are considered positive

    • This significantly reduces false positives from cross-reactivity

  • Computational Design and Engineering:

    • Apply computational approaches to identify and minimize cross-reactive epitopes

    • Engineer antibodies with enhanced specificity profiles

    • Design custom antibodies that discriminate between very similar ligands

Research on antibody specificity has shown that computational models can successfully disentangle binding modes associated with chemically similar ligands and predict antibody sequences with customized specificity profiles .

StrategyImplementationAdvantagesLimitations
AbsorptionPre-incubate with cross-reactive proteinsSimple laboratory procedureReduces antibody yield
Epitope-FocusedGenerate antibodies against unique regionsHigh specificityRequires new antibody development
Two-AntibodyUse two antibodies targeting different epitopesExcellent validationHigher cost, complex protocols
ComputationalIn silico design of high-specificity antibodiesRational design approachRequires computational expertise

How can PMEI28 antibody be used to study the role of cell wall modifications in plant defense responses?

PMEI28 antibody offers powerful tools for investigating cell wall modifications during plant defense responses :

  • Spatiotemporal Analysis of Defense Responses:

    • Track PMEI28 localization during pathogen infection using immunohistochemistry

    • Correlate PMEI28 expression with cell wall reinforcement at infection sites

    • Analyze relationship between PMEI28 expression and pectin methylesterification status

  • Defense Signaling Pathway Investigation:

    • Use PMEI28 antibody to study protein expression in response to defense hormones

    • Compare expression patterns following treatment with:

      • Jasmonic acid (JA)

      • Ethylene (ET)

      • Salicylic acid (SA)

      • Damage-associated molecular patterns (DAMPs)

  • Cell Wall Integrity Monitoring During Stress:

    • Combine PMEI28 immunodetection with cell wall modification assays

    • Analyze correlation between PMEI28 levels and:

      • Degree of pectin methylesterification

      • Cell wall porosity

      • Resistance to enzymatic degradation

      • Defense gene activation

Research has shown that PMEIs like AtPMEI10, AtPMEI11, and AtPMEI12 act as mediators of cell wall integrity maintenance in plant immunity, with their expression strictly regulated by jasmonic acid and ethylene signaling . PMEI28 research using the antibody could reveal whether it plays similar roles in rice.

What are the most effective approaches for using PMEI28 antibody in multi-parameter analyses of plant stress responses?

Multi-parameter analyses using PMEI28 antibody can provide comprehensive insights into plant stress responses :

  • Multiplexed Immunofluorescence:

    • Combine PMEI28 antibody with antibodies against other stress-related proteins

    • Use spectrally distinct fluorophores for simultaneous detection

    • Analyze colocalization and expression correlation

  • Flow Cytometry and Cell Sorting:

    • Prepare protoplasts from stressed plant tissues

    • Label with PMEI28 antibody and cell-type specific markers

    • Sort cells based on PMEI28 expression levels

    • Perform downstream transcriptomic or proteomic analysis

  • Single-Cell Resolution Analysis:

    • Combine PMEI28 immunodetection with cellular imaging techniques

    • Correlate PMEI28 expression with:

      • Cell viability markers

      • Reactive oxygen species detection

      • Calcium signaling indicators

      • Pathogen presence markers

  • CITE-seq Adaptation for Plant Research:

    • Adapt Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq)

    • Use oligo-conjugated PMEI28 antibodies

    • Simultaneously profile protein expression and transcriptome at single-cell level

Research has shown that oligo-conjugated antibodies require careful titration for optimal signal-to-noise ratio, with most antibodies reaching saturation plateau at concentrations between 0.62 and 2.5 μg/mL .

ApproachParameters MeasuredResolutionApplicationsTechnical Considerations
Multiplexed IF3-5 proteins simultaneouslyCellularSpatial protein relationshipsSpectral overlap, antibody compatibility
Flow Cytometry5-10 parametersPopulation levelCell type-specific responsesProtoplast preparation, antibody validation
Single-Cell ImagingPMEI28 + 3-4 cellular markersSubcellularPrecise localization studiesHigh-resolution microscopy, signal amplification
CITE-seqProtein + transcriptomeSingle-cellIntegrated omicsAntibody oligonucleotide conjugation optimization

How might PMEI28 antibody research contribute to engineering enhanced plant pathogen resistance?

PMEI28 antibody research can significantly contribute to engineering strategies for enhanced plant pathogen resistance :

  • Functional Characterization for Transgenic Approaches:

    • Use antibody to compare PMEI28 expression in resistant vs. susceptible varieties

    • Identify optimal expression levels and patterns for disease resistance

    • Design transgenic strategies based on expression data from antibody studies

  • Structure-Function Analysis for Protein Engineering:

    • Use antibody to purify and characterize native PMEI28

    • Determine critical regions for PME inhibition activity

    • Engineer improved PMEI28 variants with enhanced inhibitory properties

  • Screening and Phenotyping Tools for Breeding Programs:

    • Develop PMEI28 antibody-based assays to screen germplasm collections

    • Identify varieties with favorable PMEI28 expression patterns

    • Use as selection markers in breeding programs

Research has shown that plants overexpressing PMEIs (like AtPMEI1 or AtPMEI2) showed a lower level of PME activity, a higher degree of methylesterification of pectin, and reduced susceptibility to pathogens like Botrytis cinerea and Pectobacterium carotovorum . Similar strategies could be developed for PMEI28 based on antibody research findings.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.